Last updated: 16 June 2019 at 4:15pm EST

James E Flaherty Net Worth




The estimated Net Worth of James E Flaherty is at least $5.65 Milhão dollars as of 1 May 2014. James Flaherty owns over 18,189 units of Cardiovascular Systems stock worth over $2,283,540 and over the last 16 years James sold CSII stock worth over $3,364,019.

James Flaherty CSII stock SEC Form 4 insiders trading

James has made over 24 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently James sold 18,189 units of CSII stock worth $545,670 on 1 May 2014.

The largest trade James's ever made was selling 36,682 units of Cardiovascular Systems stock on 22 October 2013 worth over $984,912. On average, James trades about 8,457 units every 34 days since 2009. As of 1 May 2014 James still owns at least 114,177 units of Cardiovascular Systems stock.

You can see the complete history of James Flaherty stock trades at the bottom of the page.



What's James Flaherty's mailing address?

James's mailing address filed with the SEC is 651 CAMPUS DRIVE, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, eCapital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.



What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.



Complete history of James Flaherty stock trades at Cardiovascular Systems

Acionista maioritário
Trans.
Transação
Preço total
James E Flaherty
Chief Administrative Officer
Venda $545,670
1 May 2014
James E Flaherty
Chief Administrative Officer
Exercício de opção $385,795
30 Oct 2013
James E Flaherty
Chief Administrative Officer
Venda $984,912
22 Oct 2013
James E Flaherty
Chief Administrative Officer
Venda $41,898
19 Sep 2013
James E Flaherty
Chief Administrative Officer
Venda $62,192
17 Sep 2013
James E Flaherty
Chief Administrative Officer
Venda $147,886
28 Aug 2013
James E Flaherty
Chief Administrative Officer
Venda $190,705
23 Aug 2013
James E Flaherty
Chief Administrative Officer
Venda $25,740
15 Aug 2013
James E Flaherty
Chief Administrative Officer
Exercício de opção $239,804
13 Aug 2013
James E Flaherty
Chief Administrative Officer
Exercício de opção $206,511
8 Aug 2013
James E Flaherty
Chief Administrative Officer
Venda $210,000
3 Jun 2013
James E Flaherty
Chief Administrative Officer
Exercício de opção $249,961
28 May 2013
James E Flaherty
Chief Administrative Officer
Venda $360,000
11 Mar 2013
James E Flaherty
Chief Administrative Officer
Venda $150,000
18 Jan 2013
James E Flaherty
Chief Administrative Officer
Venda $120,000
1 Nov 2012
James E Flaherty
Chief Administrative Officer
Venda $3,188
24 Aug 2012
James E Flaherty
Chief Administrative Officer
Venda $36,443
21 Aug 2012
James E Flaherty
Chief Administrative Officer
Venda $42,407
16 Aug 2012
James E Flaherty
Chief Administrative Officer
Venda $11,337
13 Aug 2012
James E Flaherty
Chief Administrative Officer
Venda $22,687
18 Jul 2012
James E Flaherty
Chief Administrative Officer
Venda $50,050
17 Jan 2012
James E Flaherty
Chief Administrative Officer
Venda $73,269
16 Aug 2011
James E Flaherty
Chief Administrative Officer
Venda $60,636
19 Jul 2011
James E Flaherty
Chief Administrative Officer
Venda $225,000
24 May 2011


Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include: